AT193551T - as enzyme substrates and oligosaccharides - inhibitors: methods and compositions - Google Patents

as enzyme substrates and oligosaccharides - inhibitors: methods and compositions

Info

Publication number
AT193551T
AT193551T AT92909519T AT92909519T AT193551T AT 193551 T AT193551 T AT 193551T AT 92909519 T AT92909519 T AT 92909519T AT 92909519 T AT92909519 T AT 92909519T AT 193551 T AT193551 T AT 193551T
Authority
AT
Austria
Prior art keywords
oligosaccharides
inhibitors
compositions
methods
enzyme substrates
Prior art date
Application number
AT92909519T
Other languages
German (de)
Inventor
Chi-Huey Wong
Yoshitaka Ichikawa
Gwo-Jenn Shen
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US07/670,701 priority Critical patent/US5278299A/en
Priority to US70760091A priority
Priority to US73821191A priority
Priority to US85240992A priority
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Priority to PCT/US1992/002178 priority patent/WO1992016640A1/en
Publication of AT193551T publication Critical patent/AT193551T/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/18Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
AT92909519T 1991-03-18 1992-03-17 as enzyme substrates and oligosaccharides - inhibitors: methods and compositions AT193551T (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US07/670,701 US5278299A (en) 1991-03-18 1991-03-18 Method and composition for synthesizing sialylated glycosyl compounds
US70760091A true 1991-05-30 1991-05-30
US73821191A true 1991-07-30 1991-07-30
US85240992A true 1992-03-16 1992-03-16
PCT/US1992/002178 WO1992016640A1 (en) 1991-03-18 1992-03-17 Oligosaccharide enzyme substrates and inhibitors: methods and compositions

Publications (1)

Publication Number Publication Date
AT193551T true AT193551T (en) 2000-06-15

Family

ID=27505341

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92909519T AT193551T (en) 1991-03-18 1992-03-17 as enzyme substrates and oligosaccharides - inhibitors: methods and compositions

Country Status (8)

Country Link
US (3) US5593887A (en)
EP (1) EP0576592B1 (en)
JP (1) JP3476455B2 (en)
AT (1) AT193551T (en)
AU (1) AU668505B2 (en)
CA (1) CA2106301C (en)
DE (1) DE69231127D1 (en)
WO (1) WO1992016640A1 (en)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT193551T (en) * 1991-03-18 2000-06-15 Scripps Research Inst as enzyme substrates and oligosaccharides - inhibitors: methods and compositions
JPH07500248A (en) * 1991-10-15 1995-01-12
US5559103A (en) * 1993-07-21 1996-09-24 Cytel Corporation Bivalent sialyl X saccharides
DE4408248A1 (en) * 1994-03-11 1995-09-14 Hoechst Ag Physiologically tolerated and physiologically degradable carbohydrate mimetics, to a process for preparation and their use
EP0671409A3 (en) * 1994-03-11 1996-06-12 Hoechst Ag Malonic acid derivatives having anti-adhesive properties.
IT1268954B1 (en) * 1994-03-11 1997-03-18 Fidia Advanced Biopolymers Srl Process for the preparation of hyaluronic acid by sintesienzimatica and related pharmaceutical compositions
US6030815A (en) * 1995-04-11 2000-02-29 Neose Technologies, Inc. Enzymatic synthesis of oligosaccharides
US5728554A (en) * 1995-04-11 1998-03-17 Cytel Corporation Enzymatic synthesis of glycosidic linkages
US5922577A (en) * 1995-04-11 1999-07-13 Cytel Corporation Enzymatic synthesis of glycosidic linkages
US5876980A (en) * 1995-04-11 1999-03-02 Cytel Corporation Enzymatic synthesis of oligosaccharides
WO1997037682A1 (en) * 1996-04-10 1997-10-16 Cytel Corporation Nucleic acids encoding gdp-fucose pyrophosphorylase
US6399336B1 (en) 1997-01-16 2002-06-04 Neose Technologies, Inc. Practical in vitro sialylation of recombinant glycoproteins
US5952203A (en) * 1997-04-11 1999-09-14 The University Of British Columbia Oligosaccharide synthesis using activated glycoside derivative, glycosyl transferase and catalytic amount of nucleotide phosphate
EP1903114A3 (en) 1997-12-01 2008-07-23 Neose Technologies, Inc. Enzymatic synthesis of gangliosides
WO2000020428A2 (en) 1998-10-06 2000-04-13 Massachusetts Institute Of Technology Synthesis of oligosaccharides, reagents and methods related thereto
US6699705B2 (en) 1999-02-01 2004-03-02 National Research Council Of Canada Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics
US6503744B1 (en) 1999-02-01 2003-01-07 National Research Council Of Canada Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics
US6949372B2 (en) * 1999-03-02 2005-09-27 The Johns Hopkins University Engineering intracellular sialylation pathways
CA2361593A1 (en) 1999-03-02 2000-09-08 Timothy A. Coleman Human glycosylation enzymes
KR100805906B1 (en) 1999-03-12 2008-02-21 비오타 사이언티픽 매니지먼트 피티와이 엘티디 Dimeric compounds and their use as inhibitors of neuraminidase
AUPP913999A0 (en) 1999-03-12 1999-04-01 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
US6395559B1 (en) 1999-05-04 2002-05-28 Orchid Biosciences, Inc. Multiple fluid sample processor with single well addressability
DE60037113T2 (en) * 1999-05-24 2008-09-18 Abaron Biosciences, Inc., Del Mar glycosyltransferase inhibitors
AU5407300A (en) * 1999-06-30 2001-01-22 Novartis Ag Ophthalmic molding
FI19992070A (en) 1999-09-28 2001-03-28 Jari Natunen New Fucosylated oligosaccharides and a method for their preparation
JP4599505B2 (en) * 2000-03-03 2010-12-15 明治乳業株式会社 Method for producing N- acetyl -β- Hekisosaminido derivatives
US6462197B2 (en) * 2000-03-31 2002-10-08 Board Of Trustees Of Michigan State University Process for the preparation of 1,5-dideoxy-1,5-imino hexitols from oximes or imines
US6586207B2 (en) 2000-05-26 2003-07-01 California Institute Of Technology Overexpression of aminoacyl-tRNA synthetases for efficient production of engineered proteins containing amino acid analogues
US7863020B2 (en) * 2000-06-28 2011-01-04 Glycofi, Inc. Production of sialylated N-glycans in lower eukaryotes
WO2003017949A2 (en) 2001-08-29 2003-03-06 Neose Technologies, Inc. Novel synthetic ganglioside derivatives and compositions thereof
US20030096281A1 (en) * 2001-09-14 2003-05-22 Ganesh Venkataraman Methods of making glycomolecules with enhanced activities and uses thereof
AU2004236174B2 (en) 2001-10-10 2011-06-02 Novo Nordisk A/S Glycopegylation methods and proteins/peptides produced by the methods
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
DK2279755T3 (en) 2001-10-10 2014-05-26 Ratiopharm Gmbh Glycokonjugering of remodeling and fibroblast growth factor (FGF)
DK2322229T3 (en) 2001-10-10 2017-03-27 Novo Nordisk As Remodeling and glycokonjugering of Factor IX
US6852485B1 (en) 2002-01-22 2005-02-08 California State University Fullerton Foundation Method for identifying a compound for the treatment of microorganism infections by inhibiting energy storage and utilization in pathogens
AU2003256754A1 (en) 2002-07-23 2004-02-09 Governors Of The University Of Alberta Synthesis of glycoproteins using bacterial glycosyltransferases
EP2218779A1 (en) 2002-12-16 2010-08-18 Halozyme, Inc. Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof
US20060104968A1 (en) 2003-03-05 2006-05-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
EP2330213A1 (en) 2003-03-05 2011-06-08 Halozyme, Inc. Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
US7871607B2 (en) 2003-03-05 2011-01-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
JP2006519878A (en) 2003-03-06 2006-08-31 ネオーズ テクノロジーズ, インコーポレイテッド The methods and compounds for enzymatic synthesis of ganglioside
WO2005000862A2 (en) * 2003-06-24 2005-01-06 Isis Innovation Limited Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins
US9005625B2 (en) 2003-07-25 2015-04-14 Novo Nordisk A/S Antibody toxin conjugates
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
NZ556436A (en) 2005-01-10 2010-11-26 Biogenerix Ag Glycopegylated granulocyte colony stimulating factor
AU2005222782B2 (en) 2004-02-04 2010-06-17 Ratiopharm Gmbh Methods of refolding mammalian glycosyltransferases
US20050287639A1 (en) 2004-05-17 2005-12-29 California Institute Of Technology Methods of incorporating amino acid analogs into proteins
EP2586456B1 (en) 2004-10-29 2016-01-20 ratiopharm GmbH Remodeling and glycopegylation of fibroblast growth factor (FGF)
EP1871795A4 (en) 2005-04-08 2010-03-31 Biogenerix Ag Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
JP5216580B2 (en) 2005-05-25 2013-06-19 ノヴォ ノルディスク アー/エス Glycopegylated first ix factor
US7820422B2 (en) 2005-06-16 2010-10-26 Centre National De La Recherche Scientifique (Cnrs) Efficient production of oligosaccharides using metabolically engineered microorganisms
WO2007016792A1 (en) 2005-08-11 2007-02-15 National Research Council Of Canada Orf11 from campylobacter jejuni is a sialate-o-acetyltransferase
CA2619825A1 (en) 2005-08-19 2007-03-01 Centocor, Inc. Proteolysis resistant antibody preparations
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
EP1945788A4 (en) * 2005-10-17 2009-11-25 Health Research Inc Specific acceptors for tranferases to saccharides and method for obtaining and using same
WO2007056191A2 (en) 2005-11-03 2007-05-18 Neose Technologies, Inc. Nucleotide sugar purification using membranes
JP5808882B2 (en) 2006-03-03 2015-11-10 カリフォルニア インスティテュート オブ テクノロジー Site-specific incorporation of amino acids into molecules
EP2444499A3 (en) 2006-05-02 2012-05-09 Allozyne, Inc. Amino acid substituted molecules
AR078117A1 (en) 2006-06-20 2011-10-19 Protech Pharma S A A recombinant mutein of human alpha interferon glycosylated, a gene coding for said mutein, a method of producing said gene, a method for obtaining a eukaryotic cell producing such a mutein, a method for producing such a mutein, a process for purifying said mutein
US20080280818A1 (en) 2006-07-21 2008-11-13 Neose Technologies, Inc. Glycosylation of peptides via o-linked glycosylation sequences
AT503836T (en) 2006-10-03 2011-04-15 Centre Nat Rech Scient Fermentative production of sialic acid (Neu5Ac) with high yield
EP2054521A4 (en) 2006-10-03 2012-12-19 Novo Nordisk As Methods for the purification of polypeptide conjugates
US20100041872A1 (en) 2006-10-04 2010-02-18 Defrees Shawn Glycerol linked pegylated sugars and glycopeptides
EP1911850A1 (en) * 2006-10-09 2008-04-16 Centre National De La Recherche Scientifique (Cnrs) Method of producing 6-thio-sialylated glycoproteins and glycoconjugates
AR065913A1 (en) * 2007-04-02 2009-07-08 Theracos Inc Benzyl glycoside derivatives, and pharmaceutical combination composition and use
US9050304B2 (en) 2007-04-03 2015-06-09 Ratiopharm Gmbh Methods of treatment using glycopegylated G-CSF
EP2528002B1 (en) 2007-04-16 2015-11-04 Momenta Pharmaceuticals, Inc. Defined glycoprotein products and related methods
ES2551123T3 (en) 2007-06-12 2015-11-16 Ratiopharm Gmbh Improved process for the production of nucleotide sugars
EP2173759A4 (en) 2007-07-03 2014-01-29 Childrens Hosp & Res Ct Oak Oligosialic acid derivatives, methods of manufacture, and immunological uses
US8999954B2 (en) * 2007-07-03 2015-04-07 Childern's Hospital & Research Center at Oakland Inhibitors of polysialic acid de-N-acetylase and methods for using the same
CA2692417C (en) 2007-07-03 2017-03-21 Children's Hospital & Research Center At Oakland Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting
US20100260751A1 (en) 2007-09-28 2010-10-14 Raju T Shantha Methods and Structural Conformations of Antibody Preparations with Increased Resistance to Proteases
JP4826824B2 (en) * 2007-12-03 2011-11-30 クミアイ化学工業株式会社 oligosaccharide
RU2573587C2 (en) 2008-02-27 2016-01-20 Ново Нордиск А/С Conjugated factor viii molecules
WO2010111530A1 (en) 2009-03-25 2010-09-30 Seneb Biosciences, Inc. Glycolipids as treatment for disease
US20100248365A1 (en) * 2009-03-27 2010-09-30 Zacharon Pharmaceuticals, Inc. Ganglioside biosynthesis modulators
CN102481377B (en) * 2009-06-16 2014-10-29 巴斯大学 Related materials and methods are glycosylated
BR112012010252A2 (en) 2009-10-29 2016-12-06 Janssen Biotech Inc antibody glycosylation variants
CN102869784A (en) 2010-04-07 2013-01-09 动量制药公司 High mannose glycans
ES2634669T3 (en) 2011-02-08 2017-09-28 Halozyme, Inc. Lipid composition and formulation of a hyaluronan degrading enzyme and use thereof for the treatment of benign prostatic hyperplasia
US9170249B2 (en) 2011-03-12 2015-10-27 Momenta Pharmaceuticals, Inc. N-acetylhexosamine-containing N-glycans in glycoprotein products
US20130011378A1 (en) 2011-06-17 2013-01-10 Tzung-Horng Yang Stable formulations of a hyaluronan-degrading enzyme
EA030440B1 (en) 2011-10-24 2018-08-31 Галозим, Инк. Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof
ES2609582T3 (en) 2011-12-30 2017-04-21 Halozyme, Inc. PH20 polypeptide variants, formulations and uses thereof
US9695244B2 (en) 2012-06-01 2017-07-04 Momenta Pharmaceuticals, Inc. Methods related to denosumab
US10086054B2 (en) * 2013-06-26 2018-10-02 Academia Sinica RM2 antigens and use thereof
EP3240411A4 (en) * 2014-11-12 2019-02-20 Tumorend Llc Compositions, methods and treatments for inhibiting cell adhesion and virus binding and penetration
WO2018114877A1 (en) 2016-12-21 2018-06-28 F. Hoffmann-La Roche Ag In vitro glycoengineering of antibodies
WO2018114879A1 (en) 2016-12-21 2018-06-28 F. Hoffmann-La Roche Ag Method for in vitro glycoengineering of antibodies
WO2018114878A1 (en) 2016-12-21 2018-06-28 F. Hoffmann-La Roche Ag Re-use of enzymes in in vitro glycoengineering of antibodies
CN106632531B (en) * 2017-01-03 2019-02-22 河南科技学院 A kind of preparation method of α -2,3 hydroxyl acetylsalicylic acid lactulose

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2064527B (en) * 1979-12-08 1984-05-02 Nippon Shinyaku Co Ltd Moranoline derivatives and process for preparation thereof
SE451849B (en) * 1985-12-11 1987-11-02 Svenska Sockerfabriks Ab Seen to synthesize glycosidic linkages and priority over this terms derived products
JPS62242691A (en) * 1986-04-15 1987-10-23 Nippon Shinyaku Co Ltd Production of moranoline derivative
JPS62242692A (en) * 1986-04-15 1987-10-23 Nippon Shinyaku Co Ltd Production of moranoline derivative
DE3626915A1 (en) * 1986-08-08 1988-02-11 Hoechst Ag Method for the enzymatic synthesis of N-acetylneuraminic acid-containing trisaccharide
JP2504000B2 (en) * 1986-09-02 1996-06-05 日本新薬株式会社 Glucosyl model lanolin derivatives
US5039523A (en) * 1988-10-27 1991-08-13 Mycogen Corporation Novel Bacillus thuringiensis isolate denoted B.t. PS81F, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
US5045469A (en) * 1988-10-27 1991-09-03 Mycogen Corporation Novel bacillus thuringiensis isolate denoted B. T. PS81F, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
US5256788A (en) * 1989-02-13 1993-10-26 Nippon Shinyaku Co. Ltd. Moranoline derivatives and their production and the use of moranoline and its derivatives as a stabilizing agent for enzymes
US5180674A (en) * 1990-04-16 1993-01-19 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
US5278299A (en) * 1991-03-18 1994-01-11 Scripps Clinic And Research Foundation Method and composition for synthesizing sialylated glycosyl compounds
US5461143A (en) * 1991-03-18 1995-10-24 The Scripps Research Institute Oligosaccharide enzyme substrates and inhibitors: methods and compositions
AT193551T (en) * 1991-03-18 2000-06-15 Scripps Research Inst as enzyme substrates and oligosaccharides - inhibitors: methods and compositions

Also Published As

Publication number Publication date
EP0576592B1 (en) 2000-05-31
US6168934B1 (en) 2001-01-02
WO1992016640A1 (en) 1992-10-01
US5593887A (en) 1997-01-14
AU1668092A (en) 1992-10-21
EP0576592A4 (en) 1996-01-24
CA2106301A1 (en) 1992-09-19
DE69231127D1 (en) 2000-07-06
US5759823A (en) 1998-06-02
AU668505B2 (en) 1996-05-09
EP0576592A1 (en) 1994-01-05
CA2106301C (en) 1999-04-06
JP3476455B2 (en) 2003-12-10
JPH06505638A (en) 1994-06-30

Similar Documents

Publication Publication Date Title
DE69627872D1 (en) Lubricating compositions and methods
DE69516141T2 (en) enzyme inhibitors
DE69326913D1 (en) Leichtdispergierbare polydextrose compositions comprising
DK0707628T3 (en) Enveloped enzyme composition of detergents
DE69434330D1 (en) Übertragungsvorrichtgung and procedural
DE69032920T2 (en) Methods and compositions for chromosome-specific staining
DK0759089T3 (en) Treatment of glucans with enzymes
FI962315A0 (en) Enzyme inhibitors
AT214611T (en) probiotic compositions
BR9508967A (en) Intermediate compounds naphthyl processes Compositions and Methods
DK199901519A (en) In the form of small molecules present inhibitors of rotamase enzyme activity
DE69116677D1 (en) detergent composition
DE69130907T2 (en) Detergent compositions
DE69422494D1 (en) Low fat composition aufstrich
IT1270954B (en) Composition of diesel
DE69435286D1 (en) Methods and compositions for inducing sleep
DE69427161T2 (en) Gray glass composition
DE69124704T2 (en) Mixed bridge amplifier
DE69324151D1 (en) Inhibitors of the enzyme arginine ketoamide
DE69526994T2 (en) curable composition
LV12642A (en) G CSF analog compositions and Methods
FI924659A0 (en) Med uppmjukad panel foersedd baerfodral articles Foer
DK0597986T3 (en) Silk-screen process with water-based compositions
NO954525A (en) BMP-10 compositions
DE69430628D1 (en) Microemulsion and emulsion-cleansing compositions

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties